November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November 11th 2024
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
October 7th 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
September 30th 2024
Your daily dose of the clinical news you may have missed.
September 20th 2024
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 26, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Antimicrobial Resistance During COVID-19 Gained New Ground: Expert Perspective
Widespread antibiotic prescribing in the first year of the pandemic set back US progress on the fight against antimicrobial resistance, says Anne Meneghetti, MD.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 25, 2022
Three Flu Season Imperatives: Vaccinate the Young, the Old, and Everyone in Between
Influenza season in the southern hemisphere is "substantial," says Dr William Schaffner. To prepare: "Vaccinate, vaccinate, vaccinate!"
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 24, 2022
COVID-19, Flu, or Both—There are Always Patients on the Fence
The patients on the vaccine fence are the ones that take the extra time and, over time, an added measure of patience for the clinician.
Moderna Requests Emergency Use Authorization for COVID-19 Bivalent Vaccine
Moderna filed with the FDA for emergency use authorization of a 50-µg dose of a BA.4./BA.5 Omicron-targeting bivalent booster vaccine for those aged ≥18 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 23, 2022
Pfizer-BioNTech Request EUA for Bivalent COVID-19 Vaccine for Fall
Pfizer-BioNTech filed with the FDA for emergency use authorization of a 30-mcg dose of an Omicron BA.4.BA.5-adapted vaccine for those aged ≥12 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 22, 2022
HHS: Monkeypox Vaccine Production to Begin in the US as Cases Surpass 14 000
Federal officials have announced an agreement between Jynneos manufacturer Bavarian Nordic and a Michigan-based drug maker to "fill and finish" US-owned doses.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 19, 2022
William Schaffner, MD: "If It's Not Flu and It's Not COVID, It's Probably RSV"
Respiratory virus season is top of mind for Schaffner, medical director of the National Foundation for Infectious Diseases, and he says it's going to be a challenge.
COVID-19 Vaccine Risk Presented in Context Could Improve Uptake
Pair the risk of side effects associated with a COVID-19 shot with the risk of death in a car accident and see what happens. It worked in this study.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 18, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 16, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 15, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 12, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 11, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 10, 2022
FDA EUA for Monkeypox Virus Vaccine Expands Available Doses by 5-Fold
A smaller dose given by intradermal injection will expand the total US supply by a factor of 5, FDA says.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 9, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 6, 2022
Vaccine Flashcards: 4 Respiratory Virus Updates
Influenza, SARS-CoV-2, and RSV: 4 drug makers have all 3 viruses targeted for vaccines, alone and in combination. Click through the flash-card update.
Refugee Immunization Requirements: A Quick Quiz
Refresh your memory on refugee immunization recommendations with a 2-question quiz based on a patient scenario.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 5, 2022
Monkeypox Declared US Public Health Emergency by HHS
Monkeypox will now be treated as a public health emergency in the US where the outbreak has become the largest in the world, according to authorities.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 4, 2022
Impact of HPV Vaccination in US is Rising, and Herd Immunity is Getting Stronger, According to New Research
Investigators from CDC warned, however, that HPV vaccinations missed due to the COVID-19 pandemic could stymie this progress.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 3, 2022